Spectrum Library

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.

Publication Date November 2017

Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.

Publication Date December 2017

Bortezomib for Neuromyelitis Optica Spectrum Disorder – A Reply Letter

Anti myelin oligodendrocyte glycoprotein associated immunoglobulin G (AntiMOG-IgG)-associated neuromyelitis optica spectrum disorder with persistent disease activity and residual cognitive impairment

Publication Date October 2017

Spontaneous remission lasting more than a decade in untreated AQP4 antibody-positive NMOSD.

Publication Date May 2017

Reversible paraspinal muscle hyperintensity in anti-MOG antibody-associated transverse myelitis.

Publication Date October 2017

Clinical presentation and prognosis in MOG-antibody disease: a UK study.

Publication Date November 2017

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder

Publication Date August 2017

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.

Publication Date October 2017

Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.

Publication Date September 2017

What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients

Publication Date August 2017

Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.

Publication Date August 2017

Launch Dashboard

Dashboard

Fast Facts about NMOSD

NMOSD Symptoms Treatment Relapse Diagnosis Doctors Research News Advocate Helpline Resilience Events